PF-00217830

DB12998InvestigationalSmall molecule

PF-00217830 has been used in trials studying the treatment of Schizophrenia.

Chemical structure of PF-00217830
Mechanism
Curator reviewed
Formula / weight
C26H30N4O2 · 430.552 g/mol (avg)
Code names
J2.975.999E · PF-217830

Resolves to

Compound
UNII8BC08N1MS5CAS846032-02-8ChEMBLCHEMBL1774080PubChem11697676
Structure
InChIKeyQGNOXTFZOLDODX-UHFFFAOYSA-NSMILESO=C1CCC2=CC=C(OCCCCN3CCN(CC3)C3=CC=CC4=CC=CC=C34)N=C2N1
Targets
P14416DRD2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with PF-00217830, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In